| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |